Beyond CSF and neuroimaging assessment Universiteit Antwerpen Vrije Universiteit Brussel
Alzheimer's disease (AD) is the most common cause of dementia. New strategies for the early detection of MCI and sporadic AD are crucial for developing effective treatment options. Current techniques used for diagnosis of AD are invasive and/or expensive, so they are not suitable for population screening. Cerebrospinal fluid (CSF) biomarkers such as amyloid beta 1-42 (A beta 1-42), total tau (T-tau), and phosphorylated tau181 (P-tau181) levels ...